Search Results 1641-1650 of 21345 for anti-TNF drugs

1. Blood and Marrow Transplant Research Program - Transplant Research Center - Mayo Clinic Research

   Develop novel treatment approaches of GVHD; Test established and state-of-the-art GVHD treatment regimens, such as anti-thymocyte globulin (ATG), post ...

2. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   By condition, treatment or drug ... anti-PD1, anti-PDL1 or anti-CTLA4 antibodies. ... Patients under chronic treatment with systemic corticosteroids or other ...

3. A Study to Evaluate Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy for HER2+ Gastrointestinal Cancers - Mayo Clinic

   - For Cohorts 2A and 2B: prior anti-HER2 therapies - For Cohorts 1E, 1F, 1G, 2A: Prior therapy with an anti-PD-1, anti-PD-L1, or anti PD L2 agent or with an ...

4. Immune Globulin (Intramuscular Route, Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Immune globulin injection belongs to a group of medicines known as immunizing agents. ... Drugs & Supplements; Immune Globulin (Intramuscular Route, Intravenous ...

5. A Dose Escalation Study of Amivantamab in Participants with Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   Any previous treatment with systemic anti cancer immunotherapy, including but not limited to anti-PD-1, anti-PD-L1, and anti-CTLA-4 agents. For Part 1 ...

6. Neuroregeneration - Center for Regenerative Biotherapeutics - Mayo Clinic Research

   Innovative, paradigm-shifting strategies are required to advance treatment of neurological injury. The neuroregeneration research at Mayo Clinic is at the ...

7. Travel Medicine Clinics - Overview

   A country-by-country assessment of all health risks specific for your travel itinerary, such as exotic infectious agents, altitude sickness and heat exhaustion ...

8. Regadenoson (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. Transforming medicine for patients with respiratory diseases - Mayo Clinic News Network

   All were better outcomes compared to ACEis or other anti-hypertensive medications. Patients taking ACEis had a reduced risk of death in comparison to non-ARB ...

10. Next-Generation TOP1 Inhibition To Treat Ovarian Cancer - Mayo Clinic Comprehensive Cancer Center Research

    This anti-cancer activity can be enhanced by adding DNA repair modulating agents, such as PARP inhibitors and ATR inhibitors. Our researchers are conducting ...